25 Buick St
15 articles about Boston University
Key findings identify the mechanism behind how senescent cells become zombified, migraine drugs could combat obesity and new AI may identify vaccine hesitancy.
Despite having infinitely better global communications, exact figures are hard to come by for COVID-19 fatalities. Here's a look at that story and more COVID-19 news.
Details about the U.S. government’s contract with Pfizer for 10 million doses of Paxlovid are emerging, with some unusual elements.
Public health officials churn out a lot of statistics related to COVID-19, but it can often be difficult to determine just how accurate they are because there are just so many unreported test results.
LUNGevity awards inaugural Health Equity and Inclusiveness Lung Cancer Research Awards
LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced the 2021 award recipients for two new Health Equity and Inclusiveness award programs.
New Survey Reveals COVID-19 Vaccine Hesitancy Among Those with Cancer Diagnosis
Nearly 1 in 3 blood cancer patients and survivors say they are unlikely to get a COVID-19 vaccine, or unsure about it, despite their heightened risk
Polyphor receives CARB-X award of up to USD 18.44 million to support development of new antibiotic program
Polyphor AG, announced that it has received a new and second non-dilutive funding award from CARB-X, a global partnership led by Boston University dedicated to supporting the development of antibacterial products, to diagnose, prevent and treat drug-resistant infections.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
TAXIS Pharmaceuticals Announces CARB-X Award of $3.2 Million, With Potential for an Additional $11.4 Million, to Develop Efflux Pump Inhibitors (EPIs), a New Drug Class to Defeat Multi-Drug Resistant Infections
CARB-X, a global partnership led by Boston University, is awarding TAXIS Pharmaceuticals, Inc. up to $3.2 million in non-dilutive funding to develop Efflux Pump Inhibitors, representing a new drug class designed to address a major mechanism of multi-drug-resistant Pseudomonas aeruginosa bacteria.
Datavant Collaborates with Boston University to Pioneer the Use of Multi-Party Computing for Sharing Insights from Health Data
Datavant announced that it will be a founding member of the Boston University Data Privacy Collaborative, which aims to bring privacy-preserving technologies such as multi-party computing to bear on real-world applications.
CARB-X Strengthens Leadership Team with Appointment of Erin Duffy as Chief of Research and Development (R&D)
Erin Duffy to lead the growth and oversight of CARB-X’s portfolio of antibiotics, diagnostics, vaccines and other life-saving products addressing antibacterial resistance on a global level
Red Tide is a Lethal Replikins Gene Disorder
Deadly "Blooms" Over Two Years Pre-Outbreak Show Increasingly High Concentration of Gene Replikin Counts
Johnson & Johnson Innovation Announces Five-Year Alliance with Boston University to Accelerate Vision of World Without Lung Cancer
Dr. Avrum Spira Joins Johnson & Johnson Innovation as Global Head, Lung Cancer Initiative to Lead New Cancer Research Center
AAPA's Center for Healthcare Leadership and Management Partners with Northeastern University to Offer First PA Leadership and Management Certificate
The American Academy of PAs' (AAPA) Center for Healthcare Leadership and Management (CHLM) announced a partnership with Northeastern University in Boston to offer a graduate certificate in PA Leadership and Management.